AVIR

Healthcare

Atea Pharmaceuticals, Inc.

$6.09-0.01 (-0.16%)

Prev Close

$6.10

Open

$6.08

High

$6.14

Low

$5.98

Volume

367.8K

Market Cap

$480.5M

P/E

—

Div Yield

—

Over the past 12 months, insider activity at Atea Pharmaceuticals, Inc. (AVIR) has been exclusively selling, with 0 insider purchases totaling $0.00 and 6 insider sales totaling $746.7K. The most recent insider transaction was by Corcoran Andrea (See Remarks), who sold $68.3K worth of shares on Jan 31, 2026. Atea Pharmaceuticals, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $480.5M.

Buys (12M)

$0.00

Sells (12M)

$746.7K

Net Activity

Net Seller

$746.7K

Active Insiders

last 12 mo

AVIR Price Chart

AVIR Insider Trading Activity

Date	Insider	Role	Type	Shares	Avg Price	Value
Jan 31, 2026↗	Corcoran Andrea	See Remarks	Sell	16,104	$4.24	$68.3K
Jan 31, 2026↗	Foster Wayne	EVP, Chief Accounting Officer	Sell	12,132	$4.24	$51.4K
Jan 31, 2026↗	Hammond Janet MJ	Chief Development Officer	Sell	14,136	$4.24	$59.9K
Jan 31, 2026↗	Horga Maria Arantxa	Chief Medical Officer	Sell	16,073	$4.24	$68.1K
Jan 31, 2026↗	Sommadossi Jean-Pierre	President, CEO, and Chairman	Sell	106,093	$4.24	$449.8K
Jan 31, 2026↗	Vavricka John	Chief Commercial Officer	Sell	11,570	$4.24	$49.1K
Jan 31, 2025↗	Corcoran Andrea	See Remarks	Sell	16,102	$3.06	$49.3K
Jan 31, 2025↗	Foster Wayne	EVP, Chief Accounting Officer	Sell	12,062	$3.06	$36.9K
Jan 31, 2025↗	Hammond Janet MJ	Chief Development Officer	Sell	14,134	$3.06	$43.3K
Jan 31, 2025↗	Horga Maria Arantxa	Chief Medical Officer	Sell	16,071	$3.06	$49.2K
Jan 31, 2025↗	Sommadossi Jean-Pierre	President, CEO, and Chairman	Sell	88,601	$3.06	$271.1K
Jan 31, 2025↗	Vavricka John	Chief Commercial Officer	Sell	11,517	$3.06	$35.2K
Jan 15, 2025↗	BERGER FRANKLIN M	Director	Sell	25,000	$3.26	$81.5K
Dec 10, 2024↗	BERGER FRANKLIN M	Director	Sell	359,606	$2.85	$1.02M
Sep 17, 2024↗	Sommadossi Jean-Pierre	President, CEO, and Chairman	Sell	57,969	$4.04	$234.2K
Jun 20, 2024↗	Polsky Bruce	Director	Sell	17,544	$3.49	$61.1K
Jun 5, 2024↗	Sommadossi Jean-Pierre	President, CEO, and Chairman	Sell	1,006	$4.00	$4.0K
Jan 31, 2024↗	Corcoran Andrea	See Remarks	Sell	15,843	$3.84	$60.9K
Jan 31, 2024↗	Foster Wayne	EVP, Chief Accounting Officer	Sell	12,477	$3.84	$47.9K
Jan 31, 2024↗	Hammond Janet MJ	Chief Development Officer	Sell	14,029	$3.84	$53.9K
Jan 31, 2024↗	Horga Maria Arantxa	Chief Medical Officer	Sell	15,870	$3.84	$61.0K
Jan 31, 2024↗	Sommadossi Jean-Pierre	President, CEO, and Chairman	Sell	56,910	$3.85	$218.8K
Jan 31, 2024↗	Vavricka John	Chief Commercial Officer	Sell	11,819	$3.84	$45.4K
Nov 11, 2022↗	BERGER FRANKLIN M	Director	Sell	41,666	$5.15	$214.7K
Dec 20, 2021↗	Murphy Polly A.	Director	Buy	12,000	$8.57	$102.8K

AVIR Insider Buying Activity

The following table shows recent insider purchases of Atea Pharmaceuticals, Inc. (AVIR) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value	Shares After
Dec 20, 2021↗	Murphy Polly A.	Director	Buy	12,000	$8.57	$102.8K	0

AVIR Insider Selling Activity

The following table shows recent insider sales of Atea Pharmaceuticals, Inc. (AVIR) stock reported via SEC Form 4 filings.

Date	Insider	Role	Type	Shares	Avg Price	Value
Jan 31, 2026↗	Corcoran Andrea	See Remarks	Sell	16,104	$4.24	$68.3K
Jan 31, 2026↗	Foster Wayne	EVP, Chief Accounting Officer	Sell	12,132	$4.24	$51.4K
Jan 31, 2026↗	Hammond Janet MJ	Chief Development Officer	Sell	14,136	$4.24	$59.9K
Jan 31, 2026↗	Horga Maria Arantxa	Chief Medical Officer	Sell	16,073	$4.24	$68.1K
Jan 31, 2026↗	Sommadossi Jean-Pierre	President, CEO, and Chairman	Sell	106,093	$4.24	$449.8K
Jan 31, 2026↗	Vavricka John	Chief Commercial Officer	Sell	11,570	$4.24	$49.1K
Jan 31, 2025↗	Corcoran Andrea	See Remarks	Sell	16,102	$3.06	$49.3K
Jan 31, 2025↗	Foster Wayne	EVP, Chief Accounting Officer	Sell	12,062	$3.06	$36.9K
Jan 31, 2025↗	Hammond Janet MJ	Chief Development Officer	Sell	14,134	$3.06	$43.3K
Jan 31, 2025↗	Horga Maria Arantxa	Chief Medical Officer	Sell	16,071	$3.06	$49.2K
Jan 31, 2025↗	Sommadossi Jean-Pierre	President, CEO, and Chairman	Sell	88,601	$3.06	$271.1K
Jan 31, 2025↗	Vavricka John	Chief Commercial Officer	Sell	11,517	$3.06	$35.2K
Jan 15, 2025↗	BERGER FRANKLIN M	Director	Sell	25,000	$3.26	$81.5K
Dec 10, 2024↗	BERGER FRANKLIN M	Director	Sell	359,606	$2.85	$1.02M
Sep 17, 2024↗	Sommadossi Jean-Pierre	President, CEO, and Chairman	Sell	57,969	$4.04	$234.2K
Jun 20, 2024↗	Polsky Bruce	Director	Sell	17,544	$3.49	$61.1K
Jun 5, 2024↗	Sommadossi Jean-Pierre	President, CEO, and Chairman	Sell	1,006	$4.00	$4.0K
Jan 31, 2024↗	Corcoran Andrea	See Remarks	Sell	15,843	$3.84	$60.9K
Jan 31, 2024↗	Foster Wayne	EVP, Chief Accounting Officer	Sell	12,477	$3.84	$47.9K
Jan 31, 2024↗	Hammond Janet MJ	Chief Development Officer	Sell	14,029	$3.84	$53.9K
Jan 31, 2024↗	Horga Maria Arantxa	Chief Medical Officer	Sell	15,870	$3.84	$61.0K
Jan 31, 2024↗	Sommadossi Jean-Pierre	President, CEO, and Chairman	Sell	56,910	$3.85	$218.8K
Jan 31, 2024↗	Vavricka John	Chief Commercial Officer	Sell	11,819	$3.84	$45.4K
Nov 11, 2022↗	BERGER FRANKLIN M	Director	Sell	41,666	$5.15	$214.7K